Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.
Steve Rubinstein

Dr. Steve Rubinstein OD

Optometrist, Sound Shore Vision Care

What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Member of the Healthcare Council

Council Member Biography

Steve Rubinstein, OD, is a Clinical Optometrist at Diamond District Eye Associates and Sound Shore Vision Center, office based practices in New York. Dr. Rubinstein has a biochemical background. He has won the Frank R. Blood award by the Society of Toxicology for the best paper in this peer reviewed publication. Dr. Rubinstein is also an adviser with Cancer Care, Inc. and presents to groups of patients as a cancer survivor. He has interest in ocular evaluation of glaucoma using coherent lasers. Dr. Rubinstein has been a consultant to a large laser vision correction practice in New York City. (This is me - Update Profile)


Employment History

2007 - Unspecified
Optometrist, Sound Shore Vision Care
1989 - Unspecified
Optometrist, Diamond District Eye Associates

GLG NewsSM Analyses by Steve Rubinstein(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Contact Lens Nirvana: Hyperpermeable One Day

October 2, 2009

Hobby assists Irish strategy | www.opticianonline.net

 This article describes resources being put into place to mass produce the first commercially available silicon hydrogel one day disposable contact lens in the USA by Johnson & Johnson's Vistakon division.

Alcon, Novartis (Ciba Vision), Astra-Zeneca working on ocular medications?

July 23, 2009

Alcon Signs Agreement With AstraZeneca On Eye Drug Development | www.pharmaceutical-business-review.com

This agreement seems to allow Alcon Laboratories, Inc and Astra-Zeneca  to work together to produce ocular medications. What it doesn't say is that they can also use Ciba Vision's resources in the near future.

A drop in the price of OTC allergy eye drops?

July 5, 2009

Sun Pharmaceutical gets tentative nod from USFDA for ‘Optivar Solution’ | Top News | www.topnews.in

By adding a third OTC antihistamine eye drop to the mix the price competition should make the cost to the consumer decrease.

Laser Vision Correction for Presbyopia is here!

April 6, 2009

Presbyopic laser vision correction reduces spectacle dependence in pseudophakes | www.modernmedicine.com

The missing element in LVC today is real multifocal correction to deal with a the large population of baby boomers that are finding a need for a different correction for distance vision than near vision(most people over 40 years of age). As of now we have only two options for adults: 1) two eyes corrected for distance vision and reading glasses or 2) mono-vision, one eye corrected for near, and the other corrected for distance vision. We currently have the ability to create mulitfocal spectacle lenses, and multifocal contact lenses. Johnson & Johnson's Vistakon just released a new Acuvue for Presbyopia in March 2009, CooperVision and Bausch & Lomb have both had multifocal contact lenses for years.

Will contact lens solutions cost more to ship and store?

November 13, 2008

Eye Infection Epidemic Traced To Reduced Antifungal Properties Of Contact Lens Solution In High Temperatures | www.medicalnewstoday.com

A new study in Archives of Ophthalmology, November 2008 indicates that a reason for the large number of infections from Bausch & Lomb's Renu Moisture Loc solution was due to poor temperature control reducing antifungal and antimicrobial efficacy.

View All GLG News SM Analyses by Steve Rubinstein

Leading institutions connect with Steve Rubinstein through GLG

GLG Live Meetings with Steve Rubinstein(?)

Steve Rubinstein has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare